|
TTTY14 expression profile based on
|
BRCA : Breast invasive carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | N/A |
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
N/A |
| Normal-vs-Stage2 |
N/A |
| Normal-vs-Stage3 |
N/A |
| Normal-vs-Stage4 |
N/A |
| Stage1-vs-Stage2 |
N/A |
| Stage1-vs-Stage3 |
N/A |
| Stage1-vs-Stage4 |
N/A |
| Stage2-vs-Stage3 |
N/A |
| Stage2-vs-Stage4 |
N/A |
| Stage3-vs-Stage4 |
N/A |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
N/A |
| Normal-vs-AfricanAmerican |
N/A |
| Normal-vs-Asian |
N/A |
| Caucasian-vs-AfricanAmerican |
N/A |
| Caucasian-vs-Asian |
N/A |
| AfricanAmerican-vs-Asian |
N/A |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.799427E-03 |
| Normal-vs-Female |
N/A |
| Male-vs-Female |
2.668823E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
N/A |
| Normal-vs-Age(41-60Yrs) |
N/A |
| Normal-vs-Age(61-80Yrs) |
N/A |
| Normal-vs-Age(81-100Yrs) |
N/A |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
N/A |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
N/A |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
N/A |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
N/A |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
N/A |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
N/A |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Pre-menopause |
N/A |
| Normal-vs-Peri-menopause |
N/A |
| Normal-vs-Post-menopause |
N/A |
| Pre-menopause-vs-Peri-menopause |
N/A |
| Pre-menopause-vs-Post-menopause |
N/A |
| Peri-menopause-vs-Post-menopause |
N/A |
|
|
| Subtype descriptions |
| IDC | Infiltrating Ductal Carcinoma |
ILC | Infiltrating Lobular Carcinoma |
| Mixed | Mixed histology |
Mucinous | Mucinous Carcinoma |
| Medullary | Medullary Carcinoma |
Metaplastic | Metaplastic Carcinoma |
| INOS | Infiltrating Carcinoma NOS |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-IDC |
N/A |
| Normal-vs-ILC |
N/A |
| Normal-vs-Mixed |
N/A |
| Normal-vs-Other |
N/A |
| Normal-vs-Mucinous |
N/A |
| Normal-vs-Metaplastic |
N/A |
| Normal-vs-INOS |
N/A |
| Normal-vs-Medullary |
N/A |
| IDC-vs-ILC/td>
| N/A |
| IDC-vs-Mixed |
N/A |
| IDC-vs-Other |
N/A |
| IDC-vs-Mucinous |
N/A |
| IDC-vs-Metaplastic |
N/A |
| IDC-vs-INOS |
N/A |
| IDC-vs-Medullary |
N/A |
| ILC-vs-Mixed |
N/A |
| ILC-vs-Other |
N/A |
| ILC-vs-Mucinous |
N/A |
| ILC-vs-Metaplastic |
N/A |
| ILC-vs-Mixed |
N/A |
| ILC-vs-INOS |
N/A |
| ILC-vs-Medullary |
N/A |
| Mixed-vs-Other |
N/A |
| Mixed-vs-Mucinous |
N/A |
| Mixed-vs-Metaplastic |
N/A |
| Mixed-vs-INOS |
N/A |
| Mixed-vs-Medullary |
N/A |
| Other-vs-Mucinous |
N/A |
| Other-vs-Metaplastic |
N/A |
| Other-vs-INOS |
N/A |
| Other-vs-Medullary |
N/A |
| Mucinous-vs-Metaplastic |
N/A |
| Mucinous-vs-INOS |
N/A |
| Mucinous-vs-Medullary |
N/A |
| Metaplastic-vs-INOS |
N/A |
| Metaplastic-vs-Medullary |
N/A |
|
|
| Subtype descriptions |
| TNBC-BL1 | TNBC-Basal like 1 |
TNBC-BL2 | TNBC-Basal like 2 |
| TNBC-LAR | TNBC-luminal androgen receptor |
TNBC-IM | TNBC-immunomodulatory |
| TNBC-MSL | TNBC-mesenchymal stem–like |
TNBC-M | TNBC-mesenchymal |
| TNBC-UNS | TNBC-unspecified |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Luminal |
N/A |
| Normal-vs-HER2positive |
N/A |
| Normal-vs-TNBC-BL1 |
N/A |
| Normal-vs-TNBC-BL2 |
N/A |
| Normal-vs-TNBC-LAR |
N/A |
| Normal-vs-TNBC-IM |
N/A |
| Normal-vs-TNBC-M |
N/A |
| Normal-vs-TNBC-MSL |
6.823765E-01 |
| Normal-vs-TNBC-UNS |
N/A |
| Luminal-vs-HER2positive |
N/A |
| Luminal-vs-TNBC-BL1 |
N/A |
| Luminal-vs-TNBC-BL2 |
N/A |
| Luminal-vs-TNBC-LAR |
N/A |
| Luminal-vs-TNBC-IM |
N/A |
| Luminal-vs-TNBC-M |
N/A |
| Luminal-vs-TNBC-MSL |
1.176855E-01 |
| Luminal-vs-TNBC-UNS |
N/A |
| HER2Positive-vs-TNBC-BL1 |
N/A |
| HER2Positive-vs-TNBC-BL2 |
N/A |
| HER2Positive-vs-TNBC-LAR |
N/A |
| HER2Positive-vs-TNBC-IM |
N/A |
| HER2Positive-vs-TNBC-M |
N/A |
| HER2Positive-vs-TNBC-MSL |
2.737833E-01 |
| HER2Positive-vs-TNBC-UNS |
N/A |
| TNBC-BL1-vs-TNBC-BL2 |
N/A |
| TNBC-BL1-vs-TNBC-LAR |
N/A |
| TNBC-BL1-vs-TNBC-IM |
N/A |
| TNBC-BL1-vs-TNBC-M |
N/A |
| TNBC-BL1-vs-TNBC-MSL |
3.896292E-01 |
| TNBC-BL1-vs-TNBC-UNS |
N/A |
| TNBC-BL2-vs-TNBC-LAR |
N/A |
| TNBC-BL2-vs-TNBC-IM |
N/A |
| TNBC-BL2-vs-TNBC-M |
N/A |
| TNBC-BL2-vs-TNBC-MSL |
2.266746E-01 |
| TNBC-BL2-vs-TNBC-UNS |
N/A |
| TNBC-LAR-vs-TNBC-IM |
N/A |
| TNBC-LAR-vs-TNBC-M |
N/A |
| TNBC-LAR-vs-TNBC-MSL |
4.393321E-01 |
| TNBC-LAR-vs-TNBC-UNS |
N/A |
| TNBC-IM-vs-TNBC-M |
N/A |
| TNBC-IM-vs-TNBC-MSL |
2.565058E-01 |
| TNBC-IM-vs-TNBC-UNS |
N/A |
| TNBC-M-vs-TNBC-MSL |
2.703992E-01 |
| TNBC-M-vs-TNBC-UNS |
N/A |
| TNBC-MSL-vs-TNBC-UNS |
2.266746E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Luminal |
N/A |
| Normal-vs-HER2Positive |
N/A |
| Normal-vs-TNBC |
N/A |
| Luminal-vs-HER2Positive |
N/A |
| Luminal-vs-TNBC |
N/A |
| HER2Positive-vs-TNBC |
N/A |
|
|
